U.S., Aug. 8 -- ClinicalTrials.gov registry received information related to the study (NCT07110454) titled 'Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up' on July 24.
Brief Summary: The purpose of this research is to address the challenges of correctly monitoring, managing, and diagnosing epilepsy in participants whose seizures are not well captured by standard electroencephalography (EEG) tests and who cannot use or are not able to use more standard monitoring techniques. This research is being done to understand how the Minder System helps physicians make decisions about participant's epilepsy treatment after an actionable event. The Minder System was granted De Novo classification by the U.S. Food and Drug Administration (FDA...